| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9945297 | The Annals of Thoracic Surgery | 2005 | 6 Pages |
Abstract
The preoperative use of clopidogrel in patients undergoing coronary artery bypass graft surgery showed limited clinical benefits; however, its use significantly increased the risk of bleeding, blood transfusion, and resource utilization.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Jee-Yoong MBBS, Robert A. PhD, Pallav J. MCh, Vijit K. MCh, John L. (FRACS),